loader
Please Wait
Applying Filters...

Approved Drug Products containing 213137 listed in the FDA Orange Book. Original Data : FDA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2GLOBAL BLOOD THERAPS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

Brand Name : OXBRYTA

BioProcess International
Not Confirmed
arrow

Brand Name : OXBRYTA

BioProcess International
Not Confirmed
arrow

Global Blood Therapeutics

Dosage Form : TABLET; ORAL

Proprietary Name : OXBRYTA

Dosage Strength : 500MG

Approval Date : 2019-11-25

Application Number : 213137

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

Brand Name : OXBRYTA

BioProcess International
Not Confirmed
arrow

Brand Name : OXBRYTA

BioProcess International
Not Confirmed
arrow

Global Blood Therapeutics

Dosage Form : TABLET; ORAL

Proprietary Name : OXBRYTA

Dosage Strength : 300MG

Approval Date : 2022-10-14

Application Number : 213137

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank